- Patent Title: Pharmaceutical composition containing silybin, VE and L-carnitine
-
Application No.: US15560568Application Date: 2016-03-22
-
Publication No.: US10307396B2Publication Date: 2019-06-04
- Inventor: He Sun , Xijun Yan , Naifeng Wu , Kaijing Yan , Yonghong Zhu , Shunnan Zhang , Xiaolin Bai , Xiaohui Ma , Yi He , Ting Li , Lei Li
- Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.
- Applicant Address: CN Tianjin
- Assignee: Tasly Pharmaceutical Group Co., Ltd.
- Current Assignee: Tasly Pharmaceutical Group Co., Ltd.
- Current Assignee Address: CN Tianjin
- Agency: BakerHostetler LLP
- Priority: CN201510128638 20150323
- International Application: PCT/CN2016/077036 WO 20160322
- International Announcement: WO2016/150377 WO 20160929
- Main IPC: A61K31/35
- IPC: A61K31/35 ; A61K31/357 ; A61K36/82 ; A61K47/24 ; A61K9/48 ; A61K31/205 ; A61P1/16 ; A61K9/16 ; A61K31/355 ; A61K31/683 ; A61K9/08 ; A61K36/488
Abstract:
A pharmaceutical composition. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 8.75-60 parts of silybin, 15-65 parts of phospholipid, 25-200 parts of a Pu'er tea extract, 6.25-40 parts of vitamin E, and 8.3-60 parts of L-carnitine. The composition can be used for treating non-alcoholic fatty liver diseases.
Public/Granted literature
- US20180055817A1 PHARMAECUTICAL COMPOSITION CONTAINING SILYBIN, VE AND L-CARNITINE Public/Granted day:2018-03-01
Information query
